Resources from the same session
5797 - Interim Evaluation of a Targeted Radiotherapeutic, CLR 131, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients (R/R DLBCL)
Presenter: Jarrod Longcor
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
2411 - Polo-like Kinase 1 (PLK1) Inhibitor, Onvansertib, in Combination with Low-Dose Cytarabine or Decitabine in Patients with Relapsed/Refractory Acute Myeloid Leukaemia in Phase 1b
Presenter: Amer Zeidan
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
3030 - The influence of TDM on achieving busulfan target exposure and related determinants, in both children and adults who underwent an allogeneic hematopoietic cell transplantation
Presenter: Jill Boss
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
4267 - Bevacizumab for children with relapsed & refractory high risk neuroblastoma (RR-HRNB). Results of the BEACON-Neuroblastoma randomized phase 2 trial, a European ITCC-SIOPEN trial
Presenter: Lucas Moreno
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
Proffered Paper – Haematological malignancies & pediatric oncology - Invited Discussant LBA64 and 1067O
Presenter: Stefan Bielack
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Slides
Webcast